Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Persistence of Engerix-B Immunity in Children
NCT00519649Phase 4Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Primary completion
- Dec 2007
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Aug 2007; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00519649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519649.